Evidence map›Paper›PMID 33402699›Full record

ArticleJournal of human genetics2021

Expanding the phenotypic spectrum of TNFRSF11A-associated dysosteosclerosis: a case with intracranial extramedullary hematopoiesis.

Jing-Yi Xue, Pelin O Simsek-Kiper, Gulen Eda Utine, Li Yan, Zheng Wang, Ekim Z Taskiran, Beren Karaosmanoglu, Gozde Imren, Rahsan Gocmen, Gen Nishimura and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. A Null Mutation ofFrontiers in genetics · 2022
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Jing-Yi XueLaboratory for Bone and Joint Diseases, RIKEN Center for Integrative Medical Sciences, Tokyo, Japan.
Pelin O Simsek-KiperDivision of Pediatric Genetics, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Gulen Eda UtineDivision of Pediatric Genetics, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Li YanDepartment of Neurology, China-Japan Friendship Hospital, Beijing, People's Republic of China.
Zheng WangLaboratory for Bone and Joint Diseases, RIKEN Center for Integrative Medical Sciences, Tokyo, Japan.
Ekim Z TaskiranDepartment of Medical Genetics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Beren KaraosmanogluDepartment of Medical Genetics, Hacettepe University Faculty of Medicine, Ankara, Turkey.ORCID http://orcid.org/0000-0001-5564-4813
Gozde ImrenDepartment of Medical Genetics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Rahsan GocmenDepartment of Radiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Gen NishimuraLaboratory for Bone and Joint Diseases, RIKEN Center for Integrative Medical Sciences, Tokyo, Japan.
Naomichi MatsumotoDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.ORCID http://orcid.org/0000-0001-9846-6500
Noriko MiyakeDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Shiro IkegawaLaboratory for Bone and Joint Diseases, RIKEN Center for Integrative Medical Sciences, Tokyo, Japan. sikegawa@ims.u-tokyo.ac.jp.
Long GuoLaboratory for Bone and Joint Diseases, RIKEN Center for Integrative Medical Sciences, Tokyo, Japan. longguo601@gmail.com.ORCID http://orcid.org/0000-0002-9660-6941
Hacettepe University · TRRIKEN Center for Integrative Medical Sciences · JPYokohama City University · JPChina-Japan Friendship Hospital · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

Chinese Academy of Medical Sciences (CAMS) 2016-I2M-3-003Japan Agency for Medical Research and Development (AMED) 20bm0804006hJapan Agency for Medical Research and Development (AMED) 20ek0109486hJapan Agency for Medical Research and Development (AMED) JP20ek0109301Japan Agency for Medical Research and Development (AMED) JP20ek0109348Japan Agency for Medical Research and Development (AMED) JP20ek0109486Japan Agency for Medical Research and Development (AMED) JP20kk0205012MEXT | Japan Society for the Promotion of Science (JSPS) 18H02932MEXT | Japan Society for the Promotion of Science (JSPS) JP19H03621MEXT | RIKEN 201801062228
6 · The paper itself

Abstract

Dysosteosclerosis (DOS) is a rare sclerosing bone dysplasia characterized by osteosclerosis and platyspondyly. DOS is genetically heterogeneous and causally associated with mutations in three genes, SLC29A3, CSF1R, and TNFRSF11A. TNFRSF11A has been known as the causal gene for osteopetrosis, autosomal recessive 7, and is recently reported to cause DOS in three cases, which show a complex genotype-phenotype relationship. The phenotypic spectrum of TNFRSF11A-associated sclerosing bone dysplasia remains unclear and needs to be characterized further in more cases with molecular genetic diagnosis. Here, we report another TNFRSF11A-associated DOS case with a homozygous missense mutation (p.R129C). The mutation effect is different from the previous three cases, in which truncated or elongated RANK proteins were generated in isoform specific manner, thus enriching our understanding of the genotype-phenotype association in TNFRSF11A-associated sclerosing bone dysplasia. Besides DOS, our case presented with intracranial extramedullary hematopoiesis, which is an extremely rare condition and has not been identified in any other sclerosing bone dysplasias with molecular genetic diagnosis. Our findings provide the fourth case of TNFRSF11A-associated DOS and further expand its phenotypic spectrum.

Indexed as

Bone DiseasesChildChild, PreschoolFemaleGenetic Association StudiesGenetic HeterogeneityHematopoiesisHomozygoteHumansInfantIntellectual DisabilityMutationNucleoside Transport ProteinsOsteopetrosisOsteosclerosisPhenotypeCSF1R protein, humanNucleoside Transport ProteinsReceptor Activator of Nuclear Factor-kappa BReceptor, Macrophage Colony-Stimulating FactorReceptors, Granulocyte-Macrophage Colony-Stimulating FactorSLC29A3 protein, humanTNFRSF11A protein, human

Identifiers

PMID33402699
OpenAlexW3120633097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.